LLY

1,024.93

+1.7%↑

JNJ

211.32

+0.84%↑

ABBV

222.39

-0.23%↓

UNH

341.33

+1.48%↑

AZN

89.83

-0.92%↓

LLY

1,024.93

+1.7%↑

JNJ

211.32

+0.84%↑

ABBV

222.39

-0.23%↓

UNH

341.33

+1.48%↑

AZN

89.83

-0.92%↓

LLY

1,024.93

+1.7%↑

JNJ

211.32

+0.84%↑

ABBV

222.39

-0.23%↓

UNH

341.33

+1.48%↑

AZN

89.83

-0.92%↓

LLY

1,024.93

+1.7%↑

JNJ

211.32

+0.84%↑

ABBV

222.39

-0.23%↓

UNH

341.33

+1.48%↑

AZN

89.83

-0.92%↓

LLY

1,024.93

+1.7%↑

JNJ

211.32

+0.84%↑

ABBV

222.39

-0.23%↓

UNH

341.33

+1.48%↑

AZN

89.83

-0.92%↓

Search

Baxter International Inc

Avatud

SektorTervishoid

19.13 2.9

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

18.56

Max

19.33

Põhinäitajad

By Trading Economics

Sissetulek

-137M

-15M

Müük

25M

2.8B

P/E

Sektori keskmine

86.308

77.671

Aktsiakasum

0.69

Dividenditootlus

3.67

Kasumimarginaal

-0.529

Töötajad

38,000

EBITDA

-46M

416M

Soovitused

By TipRanks

Soovitused

Neutraalne

12 kuu keskmine prognoos

+27.16% upside

Dividendid

By Dow Jones

Dividenditootlus

Sektori keskmine

3.67%

2.35%

Järgmine dividendimakse kuupäev

2. jaan 2026

Turustatistika

By TradingEconomics

Turukapital

-2.6B

9.3B

Eelmine avamishind

16.23

Eelmine sulgemishind

19.13

Uudiste sentiment

By Acuity

70%

30%

343 / 374 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Weak Bullish Evidence

Baxter International Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

11. dets 2025, 23:58 UTC

Omandamised, ülevõtmised, äriostud

Destination XL to Merge With Oaktree-Backed Fullbeauty Brands -- Update

11. dets 2025, 23:56 UTC

Tulu

Costco Logs Higher Sales, Eyes Expansion to Fuel Membership Growth -- Update

11. dets 2025, 23:03 UTC

Omandamised, ülevõtmised, äriostud

FTC Sues to Block Henkel's $725 Million Acquisition of Liquid Nails From PE Firm

11. dets 2025, 22:06 UTC

Omandamised, ülevõtmised, äriostud

Scentre to Sell $456 Million Westfield Chermside Mall Stake to Dexus-Managed Fund

11. dets 2025, 21:50 UTC

Tulu

Costco Same-Store Sales, Membership Fees Rose in 1Q

11. dets 2025, 23:45 UTC

Market Talk

Global Equities Roundup: Market Talk

11. dets 2025, 23:44 UTC

Market Talk

Nikkei May Rise After U.S. Stock Indexes Hit Record Highs -- Market Talk

11. dets 2025, 23:37 UTC

Market Talk

Gold Steady, Underpinned by Dollar's Weakness -- Market Talk

11. dets 2025, 23:31 UTC

Tulu

Broadcom Beats Revenue and Profit Forecasts as AI Chip Sales Climb -- Update

11. dets 2025, 22:48 UTC

Omandamised, ülevõtmised, äriostud

FTC Sues to Block Henkel's $725M Acquisition of Liquid Nails From PE Firm

11. dets 2025, 22:35 UTC

Tulu

Costco Sold 4.5 Million Pies Ahead of Thanksgiving. Despite Earnings Beat, the Stock Fails to Gain Traction. -- Barrons.com

11. dets 2025, 22:30 UTC

Tulu

Broadcom Beats Earnings. The Stock Wavers After Customer Updates. -- Barrons.com

11. dets 2025, 22:09 UTC

Omandamised, ülevõtmised, äriostud

FTC Alleges Henkel Deal Would Combine Two Biggest Brands of Construction Adhesives Sold at Stores Like Home Depot, Leading to Higher Prices

11. dets 2025, 22:06 UTC

Omandamised, ülevõtmised, äriostud

FTC Sues to Block Henkel From Buying Loctite Competitor Liquid Nails

11. dets 2025, 22:05 UTC

Tulu

Broadcom Beats Revenue and Profit Forecasts as AI Chip Sales Climb -- Update

11. dets 2025, 21:51 UTC

Omandamised, ülevõtmised, äriostud

Scentre to Sell $456M Westfield Chermside Mall Stake to Dexus-Managed Fund

11. dets 2025, 21:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

11. dets 2025, 21:39 UTC

Tulu

Broadcom Beats Earnings. The Stock Rises. -- Barrons.com

11. dets 2025, 21:39 UTC

Tulu

Broadcom Reports $18 Billion in Revenue as AI Chip Sales Climb -- WSJ

11. dets 2025, 21:38 UTC

Tulu

Costco Tops Earnings Estimates but Stock Fails to Gain Traction -- Barrons.com

11. dets 2025, 21:37 UTC

Tulu

These Stocks Moved the Most Today: Oracle, Nvidia, Broadcom, Planet Labs, Visa, Ciena, Gemini Space Station, and More -- Barrons.com

11. dets 2025, 21:37 UTC

Market Talk

Broadcom Sees AI Revenue Doubling -- Market Talk

11. dets 2025, 21:34 UTC

Omandamised, ülevõtmised, äriostud

Scentre Will Temporarily Invest A$50M in the New Dexus Fund

11. dets 2025, 21:29 UTC

Omandamised, ülevõtmised, äriostud

Dexus Aiming for Long-Term Holding of A$50M in Fund

11. dets 2025, 21:28 UTC

Market Talk

BLS Publishing Calendar Delays Now Pushing Economic Data Into February -- Market Talk

11. dets 2025, 21:28 UTC

Omandamised, ülevõtmised, äriostud

Dexus Expects to Introduce Additional Third-Party Equity in FY26

11. dets 2025, 21:28 UTC

Omandamised, ülevõtmised, äriostud

Dexus: Third Party Investors to Contribute Remainder

11. dets 2025, 21:27 UTC

Omandamised, ülevõtmised, äriostud

Dexus to Put Initial A$170M into New Dexus Strategic Investment Trust

11. dets 2025, 21:26 UTC

Omandamised, ülevõtmised, äriostud

Scentre: Dexus Wholesale Shopping Centre Fund Already Holds 25% Stake

11. dets 2025, 21:25 UTC

Omandamised, ülevõtmised, äriostud

Scentre: Purchase Price Represents Book Value, 5% Value Cap Rate

Võrdlus sarnastega

Hinnamuutus

Baxter International Inc Prognoos

Hinnasiht

By TipRanks

27.16% tõus

12 kuu keskmine prognoos

Keskmine 23.22 USD  27.16%

Kõrge 36 USD

Madal 15 USD

Põhineb 10 Wall Streeti analüütiku instrumendi Baxter International Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Neutraalne

10 ratings

2

Osta

7

Hoia

1

Müü

Tehniline skoor

By Trading Central

30.475 / 31.345Toetus ja vastupanu

Lühikene perspektiiv

Weak Bullish Evidence

Keskpikk perspektiiv

Bearish Evidence

Pikk perspektiiv

Bearish Evidence

Sentiment

By Acuity

343 / 374 Pingereas Tervishoid

Uudiste sentiment

Tõusu märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Baxter International Inc

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories. It also provides administrative sets; adhesion prevention products; inhaled anesthesia; drug compounding; chronic and acute dialysis therapies and services, including peritoneal dialysis (PD), hemodialysis (HD), continuous renal replacement therapies (CRRT), and other organ support therapies. The company's products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic products; and a collaborative research agreement with Miromatrix Medical Inc. aiming to advance care for patients with acute liver failure. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.
help-icon Live chat